Program

Team & Instructors

Current Course Directors

Guest Instructors & Lecturers (2015-Present)

  • Marc Appel, JD, MBA, Managing Partner, Pacific Bridge
  • Michael Baran, PhD, MBA, Head of Private Investments, Affinity Healthcare; Former Partner, Pfizer Ventures
  • Erick Berglund, PhD, Co-Founder and CSO, Intrommune Therapeutics
  • Heather Bielski Lawler, Innovation Project Manager, DUKAL Corporation
  • Michael Bielski, JD, Founder and President, DevTech Partners
  • Derek Brand, MBA, Executive Director, Strategic Partnerships, Columbia University
  • Kara Cannon, CEO, Tesla Science Center at Wardenclyffe (TSCW)
  • Bryan Czyzewski, PhD, Managing Director in Healthcare Investment Banking, Jefferies
  • Dee Dao, PhD, Associate Director, Business Development and Technology, Center for Biotechnology
  • Richard Delle Bovi, PhD,Product Manager, The Jackson Laboratory
  • Javan Esfandiari, PhD, President & CSTO, Chembio Diagnostic Systems, Inc.
  • Eric Greenbaum, MS, JD, Manager, Business Development & Technology Transfer, Cold Spring Harbor Laboratory
  • Angelo Gunasekera, Senior Director of R&D, Chembio Diagnostic Systems Inc.
  • Ron Katz, PhD, VP, Head of Business Development & Intellectual Property, Spur Therapeutics
  • Craig S. Kenesky, PhD, Partner, Brown Rudnick
  • Jon Klein, Co-Founder & President, Kantian Sciences Corporation
  • Sharon Klugewicz, MSc, Sr. VP Quality & Regulatory Affairs, Spectrum Vascular
  • Avi Kometz, MD, Partner, Deerfield Management
  • Alan J. Morrison, JD, Law Offices of Alan J. Morrison; Adjunct Lecturer in Biological Sciences, Columbia Bioscience
  • Glen Park, Former VP Regulatory Affairs, SCYNEXIS
  • Andrew Protter, PhD, CEO, 1cBio, Inc.; Former Vice President-Preclinical Development, Medivation, Inc.
  • Brendan P. Rae, PhD, CEO, Baxgen Therapeutics
  • Donna See, MPH, MBA, Founder and CEO Xora Innovation
  • Joseph Scaduto, MS, MBA, Co-founder and CEO, CMTx Biotech Inc.
  • Geoffrey W. Smith, Co-Founder and Managing Partner, Ascent Biomedical Ventures, L.P.
  • Johnna St Clair, PhD, Associate Director, Field Medical Operations, Freenome
  • Saied Tousi, PhD, CEO, USVOLT
  • Eric Vieira, PhD, Vice President, Strategic Partnerships, New York University
  • Lisa Wisniewski, PhD,Managing Director, Global BioAccess Fund
  • Anton Xavier, MS, MBA, Founder & CEO, K-9 Biotech; CEO, iNanoRNA Therapeutics